- Home
- FDBC vs GOSS Comparison
FDBC vs GOSS Comparison
Compare FDBC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- GOSS
- Stock Information
- Founded
- FDBC 1902
- GOSS 2015
- Country
- FDBC United States
- GOSS United States
- Employees
- FDBC N/A
- GOSS N/A
- Industry
- FDBC Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- FDBC Finance
- GOSS Health Care
- Exchange
- FDBC Nasdaq
- GOSS Nasdaq
- Market Cap
- FDBC 246.3M
- GOSS 214.7M
- IPO Year
- FDBC N/A
- GOSS 2019
- Fundamental
- Price
- FDBC $50.68
- GOSS $0.97
- Analyst Decision
- FDBC
- GOSS Strong Buy
- Analyst Count
- FDBC 0
- GOSS 5
- Target Price
- FDBC N/A
- GOSS $9.20
- AVG Volume (30 Days)
- FDBC 9.5K
- GOSS 955.5K
- Earning Date
- FDBC 10-23-2024
- GOSS 11-07-2024
- Dividend Yield
- FDBC 3.00%
- GOSS N/A
- EPS Growth
- FDBC N/A
- GOSS N/A
- EPS
- FDBC 2.75
- GOSS N/A
- Revenue
- FDBC $70,433,000.00
- GOSS $95,842,000.00
- Revenue This Year
- FDBC N/A
- GOSS N/A
- Revenue Next Year
- FDBC N/A
- GOSS N/A
- P/E Ratio
- FDBC $18.46
- GOSS N/A
- Revenue Growth
- FDBC N/A
- GOSS N/A
- 52 Week Low
- FDBC $41.10
- GOSS $0.45
- 52 Week High
- FDBC $60.85
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- FDBC 53.80
- GOSS 48.28
- Support Level
- FDBC $47.31
- GOSS $0.98
- Resistance Level
- FDBC $48.73
- GOSS $1.09
- Average True Range (ATR)
- FDBC 1.13
- GOSS 0.06
- MACD
- FDBC -0.05
- GOSS -0.01
- Stochastic Oscillator
- FDBC 100.00
- GOSS 21.83
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.